OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity
Status: | Terminated |
---|---|
Conditions: | Neurology, Neurology |
Therapuetic Areas: | Neurology |
Healthy: | No |
Age Range: | 18 - 80 |
Updated: | 4/21/2016 |
Start Date: | May 2014 |
End Date: | December 2015 |
This is a safety and efficacy study of onabotulinumtoxinA in poststroke patients with upper
limb spasticity.
limb spasticity.
Inclusion Criteria:
- Upper limb spasticity in the elbow and shoulder due to stroke, with the most recent
stroke at least 3 months ago
Exclusion Criteria:
- Spasticity in the non-study upper limb that requires treatment
- Presence of fixed contractures in of the study muscles in elbow or shoulder
- Profound atrophy of muscles to be injected
- Previous surgical intervention, nerve block, or muscle block for the treatment of
spasticity in the study limb in the last 12 months
- Injection of corticosteroids or anesthetics, use of casting or dynamic splinting or
constraint-induced movement therapy (CIMT) for the study limb within 3 months
- Ultrasound therapy, electrical stimulation, or acupuncture in the study limb within 1
month
- Condition other than stroke contributing to upper limb spasticity
- Diagnosis of myasthenia gravis, Eaton-Lambert syndrome, and/or amyotrophic lateral
sclerosis
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials